Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2015013838
pages 199-202

AKT as Locus of Cancer Positive Loops Conversion and Chemotherapy

Ziv Radisavljevic
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115

ABSTRAKT

A cancer positive-feedback loops conversion is the phenomenon and principal mechanism for AKT locus chemotherapy. Such chemotherapy is the approach to target cancer robustness and complexity through the AKT signaling locus. The hypoxic cancer microenvironment generates a powerful signaling interactome with positive-feedback loops that generates cancer robustness through the AKT locus. This complexity and robustness can be successfully halted in leukemia, lymphoma, myeloma, plasmocytoma, sarcoma, and carcinoma by converting cancer positive-feedback loops into negative-feedback loops, achieved through the AKT dephosphorylation by redox balancing change. The hyperphosphorylated AKT locus is down-regulated completely to AKT dephosphorylation by redox balancing change, causing conversion of positive-feedback loops and the disappearance of malignant robustness as a direct effect of AKT locus chemotherapy.


Articles with similar content:

Profiles of Radioresistance Mechanisms in Prostate Cancer
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 1-2
Daret K. St. Clair, Rani D. Jayswal, Heidi L. Weiss, Luksana Chaiswing, Natasha Kyprianou
Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
Silvana Canevari, Manuel Penichet, Sara Huerta-Yepez, Marialuisa Sensi, Ma da Lourdas Cabrava-Haimandez, Haiming Chen, Massimo Libra, Stavroula Baritaki, James R. Berenson, Benjamin Bonavida
Regulating RNA Binding Motif 5 Gene Expression− A Novel Therapeutic Target for Lung Cancer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Niranjali Devaraj, Venugopal Vinod Prabhu
The Transcription Regulator Kruppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Swapan K. Ray
Mechanophysical-Chemotherapy Combinations: A Dual Approach to Combat Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 3
Suruchi S. Vasudev, Farhan Jalees Ahmad, Rabea Parveen, Sushama Talegaonkar, Zeenat Iqbal